Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
However, in a randomized phase III double-blind clinical trial, tivantinib did not improve OS time in patients with Met-high advanced HCC treated with sorafenib compared with placebo (Rimassa et al., 2018) (NCT01755767)
Cancer Letters , 183(1), 1-8
doi:10.1210/jcem-67-6-1186
Therefore, at Sandhus we provide a high-quality research-based formulation with prebiotic, probiotic, and postbiotic with preservation support in a delayed-release capsule to prevent nutrients from being broken down in the stomach so they could be released in the small intestine where it can thrive
US$ 24.18
US$ 25.99
US$ 21.28
US$ 25.66
US$ 20.77
US$ 22.55
US$ 21.24
US$ 23.39
US$ 20.32
US$ 24.79
